{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:03Z","timestamp":1786990263426,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.humpath.2016.09.027","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T17:35:04Z","timestamp":1476898504000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Expression of cathepsins V and S in thymic epithelial tumors"],"prefix":"10.1016","volume":"60","author":[{"given":"Shizuka","family":"Kiuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utano","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Imagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuji","family":"Marukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2016.09.027_bb0005","first-page":"68","article-title":"Cysteine cathepsins: from structure, function, and regulation to new frontiers","volume":"2012","author":"Turk","year":"1824","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2016.09.027_bb0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0092-8674(00)81025-9","article-title":"Invariant chain structure and MHC class II function","volume":"84","author":"Cresswell","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2016.09.027_bb0015","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI42918","article-title":"Specialized roles for cysteine cathepsins in health and disease","volume":"120","author":"Reiser","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2016.09.027_bb0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nri2187","article-title":"Generating intrathymic microenvironments to establish T-cell tolerance","volume":"7","author":"Anderson","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/jclinpath-2013-201930","article-title":"Expression of thymoproteasome subunit \u03b25t in type AB thymoma","volume":"67","author":"Yamada","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0030","series-title":"WHO classification of tumors of the lung, pleura, thymus, and heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.humpath.2016.09.027_bb0035","series-title":"Tumours of the thymus","author":"Muller-Hermelink","year":"2004"},{"key":"10.1016\/j.humpath.2016.09.027_bb0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","article-title":"ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting","volume":"9","author":"Marx","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0045","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/JTO.0000000000000297","article-title":"Histologic classification of thymoma: a practical guide for routine cases","volume":"9","author":"den Bakker","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0050","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 World Health Organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0055","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.1141915","article-title":"Regulation of CD8+ T cell development by thymus-specific proteasomes","volume":"316","author":"Murata","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.humpath.2016.09.027_bb0060","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1182\/blood-2008-11-187633","article-title":"Exclusive expression of proteasome subunit \u03b25t in the human thymic cortex","volume":"113","author":"Tomaru","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2016.09.027_bb0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/PAS.0b013e3182237f5d","article-title":"Expression of proteasome subunit \u03b25t in thymic epithelial tumors","volume":"35","author":"Yamada","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcp\/106.4.483","article-title":"CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue","volume":"106","author":"Berezowski","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0075","first-page":"268","article-title":"CD5 expression in thymic carcinoma","volume":"145","author":"Hishima","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2016.09.027_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/modpathol.2009.105","article-title":"Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms","volume":"22","author":"Kojika","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2016.09.027_bb0095","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.prp.2015.10.005","article-title":"Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes","volume":"211","author":"Thomas de Montpreville","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2016.09.027_bb0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00005-013-0234-1","article-title":"Thymoproteasome: role in thymic selection and clinical significance as a diagnostic marker for thymic epithelial tumors","volume":"61","author":"Tomaru","year":"2013","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.humpath.2016.09.027_bb0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1515\/BC.2004.132","article-title":"Cysteine cathepsins in human cancer","volume":"385","author":"Jedeszko","year":"2004","journal-title":"Biol Chem"},{"key":"10.1016\/j.humpath.2016.09.027_bb0110","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrc4027","article-title":"Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response","volume":"15","author":"Olson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2016.09.027_bb0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/prca.201300085","article-title":"Cysteine cathepsins and their potential in clinical therapy and biomarker discovery","volume":"8","author":"Fonovic","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.humpath.2016.09.027_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1535-6108(04)00111-4","article-title":"Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis","volume":"5","author":"Joyce","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817716302520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817716302520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:57:07Z","timestamp":1536307027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817716302520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":24,"alternative-id":["S0046817716302520"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2016.09.027","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of cathepsins V and S in thymic epithelial tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2016.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}